STRA6 anticorps (PE)
Aperçu rapide pour STRA6 anticorps (PE) (ABIN1712739)
Antigène
Voir toutes STRA6 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human STRA6
-
Isotype
- IgG
-
-
-
-
Indications d'application
- FCM(1:20-100)
-
Commentaires
-
Exitation/Emission: 480,565nm/578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4°C
-
Date de péremption
- 12 months
-
-
- STRA6 (Stimulated By Retinoic Acid 6 (STRA6))
-
Autre désignation
- Stra6
-
Sujet
-
STRA6 is a 667 amino acid, multi-pass cell membrane protein. Stra6 functions as a cell-surface receptor for the complex retinol-retinol binding protein (RBP/RBP4). Ultimately increasing cellular retinol uptake from the retinol-RBP complex, Stra6 removes retinol from RBP/RPB4 and transports it across the plasma membrane, where it is metabolized. Stra6 is broadly expressed, with 4 named isoforms that exist as a result of alternative splicing events. Mutations in the gene encoding Stra6 cause Matthew-Wood Syndrome, also known as Spear Syndrome. This syndrome is characterized by anophtalmia, mild facial dysmorphism and malformations of the heart, lung and diaphragm. The Stra6 gene maps to chromosome 15q24.1.
Subcellular location: Extracellular
Synonyms: Stimulated by retinoic acid gene 6 protein homolog, STRA6_HUMAN. -
ID gène
- 64220
-
Pathways
- Feeding Behaviour
Antigène
-